Burke & Herbert Bank & Trust Co. reduced its stake in shares of Express Scripts Holding Co. (NASDAQ:ESRX) by 5.9% during the second quarter, Holdings Channel reports. The fund owned 4,495 shares of the company’s stock after selling 284 shares during the period. Burke & Herbert Bank & Trust Co.’s holdings in Express Scripts Holding were worth $341,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Oakworth Capital Inc. raised its stake in shares of Express Scripts Holding by 966.7% in the second quarter. Oakworth Capital Inc. now owns 1,792 shares of the company’s stock valued at $136,000 after buying an additional 1,624 shares during the last quarter. Alpha Windward LLC raised its stake in shares of Express Scripts Holding by 30.7% in the second quarter. Alpha Windward LLC now owns 1,988 shares of the company’s stock valued at $151,000 after buying an additional 467 shares during the last quarter. Community Trust & Investment Co. purchased a new stake in shares of Express Scripts Holding during the second quarter valued at about $203,000. Northstar Group Inc. purchased a new stake in shares of Express Scripts Holding during the second quarter valued at about $204,000. Finally, Agran Libbie purchased a new stake in shares of Express Scripts Holding during the second quarter valued at about $205,000. Hedge funds and other institutional investors own 88.52% of the company’s stock.
Shares of Express Scripts Holding Co. (NASDAQ:ESRX) traded up 0.01% during mid-day trading on Thursday, reaching $70.35. The company’s stock had a trading volume of 2,771,710 shares. Express Scripts Holding Co. has a one year low of $65.55 and a one year high of $89.20. The firm’s 50 day moving average is $72.12 and its 200 day moving average is $73.72. The firm has a market cap of $44.34 billion, a PE ratio of 17.38 and a beta of 1.16.
Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Monday, July 25th. The company reported $1.57 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $1.57. Express Scripts Holding had a return on equity of 23.98% and a net margin of 2.64%. The business earned $25.20 billion during the quarter, compared to analyst estimates of $25.42 billion. During the same quarter in the previous year, the business earned $1.44 earnings per share. The company’s revenue for the quarter was down .9% compared to the same quarter last year. On average, equities analysts anticipate that Express Scripts Holding Co. will post $6.36 earnings per share for the current fiscal year.
Several analysts have issued reports on ESRX shares. Zacks Investment Research upgraded Express Scripts Holding from a “hold” rating to a “buy” rating and set a $88.00 target price on the stock in a research note on Wednesday, July 27th. Jefferies Group decreased their price objective on Express Scripts Holding from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Tuesday, July 26th. Credit Suisse Group AG reiterated a “buy” rating on shares of Express Scripts Holding in a research note on Monday, June 27th. Leerink Swann reiterated a “market perform” rating and set a $80.00 price objective on shares of Express Scripts Holding in a research note on Thursday, September 1st. Finally, Mizuho boosted their price objective on Express Scripts Holding from $77.00 to $82.00 and gave the company a “neutral” rating in a research note on Tuesday, August 2nd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and nine have assigned a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $81.53.
In related news, VP Christopher A. Mcginnis sold 1,785 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The stock was sold at an average price of $70.77, for a total value of $126,324.45. Following the completion of the sale, the vice president now owns 4,955 shares in the company, valued at $350,665.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Woodrow A. Myers, Jr. sold 12,036 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The shares were sold at an average price of $70.40, for a total value of $847,334.40. Following the completion of the sale, the director now owns 14,918 shares of the company’s stock, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. 0.54% of the stock is owned by corporate insiders.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co. (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related companies with MarketBeat.com's FREE daily email newsletter.